Search - tctmd.com

Displaying 201 - 220 of 552

Sort: Relevancy | Date

5-Year RESTORE SVD China Trial: Restore DCB vs. DES Resolute Integrity in SVD

Presentation TCT 2022

5-Year RESTORE SVD China Trial: Restore DCB vs. DES Resolute Integrity in SVD

Presenter: ShaoLiang Chen

September 17, 2022

3-Year Outcome of paclitaxel DCB vs. DES for Native Vessel Disease Treatment: Final Follow Up of the Randomized PICCOLETO II Trial

Presentation TCT 2022

3-Year Outcome of paclitaxel DCB vs. DES for Native Vessel Disease Treatment: Final Follow Up of the Randomized PICCOLETO II Trial

Presenter: Bernardo Cortese

September 17, 2022

Time to Move Beyond ISR – My Vision of the Future for Coronary DCB Technologies

Presentation TCT 2022

Time to Move Beyond ISR – My Vision of the Future for Coronary DCB Technologies

Presenter: Antonio Colombo

September 17, 2022

Presentation TCT 2022

Welcome

Presenter: Desmond Adler

September 17, 2022

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

News Conference News TCT 2022

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

September 16, 2022

News Industry News

NIH - Sponsored Trial of Pharmaco-mechanical Thrombolysis with the BASHIRTM Endovascular Catheter Demonstrates Unprecedented Reduction in Pulmonary Artery Obstruction in Patients with Acute Pulmonary Embolism

September 16, 2022

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

AI Tool Can Quantify CAC—and Associated CV Risk—From PET

News Daily News

AI Tool Can Quantify CAC—and Associated CV Risk—From PET

Yael L. Maxwell

September 14, 2022

News Industry News

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

September 13, 2022

Beyond the Shining Lights and Science at ESC: Bullying Works in Shadows

News Opinion Over the Wire

Beyond the Shining Lights and Science at ESC: Bullying Works in Shadows

Mamas Mamas, BMBCh

September 08, 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

Early Rhythm Control Also May Help Lower-Risk AF Patients

News Daily News

Early Rhythm Control Also May Help Lower-Risk AF Patients

September 07, 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

September 07, 2022

Routine Functional Testing Unnecessary After Stenting: POST-PCI

News Conference News ESC 2022

Routine Functional Testing Unnecessary After Stenting: POST-PCI

Yael L. Maxwell

September 06, 2022

Monkeypox and the Heart: Acute Myocarditis Rare, With Good Outlook

News Daily News

Monkeypox and the Heart: Acute Myocarditis Rare, With Good Outlook

September 02, 2022

ESC Revamps Guidelines on Ventricular Arrhythmias, Sudden Cardiac Death

News Conference News ESC 2022

ESC Revamps Guidelines on Ventricular Arrhythmias, Sudden Cardiac Death

September 02, 2022

Stable Chest Pain Guideline Data Standards Developed to Add Uniformity

News Daily News

Stable Chest Pain Guideline Data Standards Developed to Add Uniformity

Yael L. Maxwell

September 02, 2022

COVID-PACT: Full-Dose Anticoagulation Improves Outcomes in Critical COVID-19

News Conference News ESC 2022

COVID-PACT: Full-Dose Anticoagulation Improves Outcomes in Critical COVID-19

September 01, 2022

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

News Conference News ESC 2022

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

Yael L. Maxwell

August 31, 2022

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

News Conference News ESC 2022

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

Michael O'Riordan

August 31, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.